Legal pressures and incentives for personalized medicine

Gary Marchant, Robert J. Milligan, Brian Wilhelmi

Research output: Contribution to journalArticlepeer-review

15 Scopus citations


Legal liability has the potential to be a powerful driver pushing implementation of personalized medicine. Individuals injured by adverse drug effects are increasingly likely to bring lawsuits alleging that they have a polymorphism or biomarker conferring susceptibility to the drug that should have been identified and used to alter their drug treatment. Likely targets of such lawsuits include drug manufacturers, third party payors, physicians and pharmacists, of which physicians are most at risk of substantial liability.

Original languageEnglish (US)
Pages (from-to)391-397
Number of pages7
JournalPersonalized Medicine
Issue number4
StatePublished - Nov 2006


  • Failure-to-warn
  • Liability
  • Medical malpractice
  • Personalized medicine
  • Pharmacogenomics

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology


Dive into the research topics of 'Legal pressures and incentives for personalized medicine'. Together they form a unique fingerprint.

Cite this